drugset / Trial / NCT02293655
The Effects of ADHD Medication (TEAM) Study
Phase 4
Completed
204 enrolled
Children's Hospital Medical Center, Cincinnati
Seattle Children's Hospital · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study evaluates the effects of receiving and then discontinuing methylphenidate (MPH) in children with ADHD. After receiving MPH for 8 weeks, participants will be randomized to either discontinue MPH (and receive placebo) OR remain on MPH for 4 weeks.
Timeline
- Start
- 2015-01-12
- Primary completion
- 2020-06-30
- Completion
- 2021-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Methylphenidate | Small molecule | 18 mg | Oral |
| Comparator | Methylphenidate | Small molecule | 27 mg | Oral |
| Comparator | Methylphenidate | Small molecule | 36 mg | Oral |
| Comparator | Methylphenidate | Small molecule | 54 mg | Oral |